2025-06-12 –, BS 3.14 - 60 cap.
Background: While drug checking services are often viewed as a modern harm reduction innovation, they have a rich but understudied history in the United States. Throughout the 1970s and 1980s, "street drug" analysis services analyzed and reported on illicit substances in the drug supply. Objectives: This study aims to (1) create a comprehensive dataset of historical drug checking results, (2) digitize and preserve underground newsletters for future research, and (3) analyze patterns in drug supply quality and harm reduction messaging during this era. Methods: We compiled and coded approximately 30,000 drug analysis results from historical reports, documenting alleged substances, tested contents, physical characteristics, purity, price, and location, among other features. We also conducted content analysis of hundreds of underground newsletters discussing drug analysis results and safe supply messaging.
Results: Analysis reveals significant rates of drug misrepresentation in the illicit market, with variations across substance types and geographical regions. Content analysis of underground newsletters demonstrates consistent themes advocating for safe supply and critiquing how drug prohibition compromises user safety. The newsletters also provide crucial context about data quality and reporting practices. Implications: This research illuminates enduring challenges in drug policy and harm reduction. Current restrictions on quantitative results reporting by anonymous drug checking services echo historical barriers to harm reduction efforts. These findings inform ongoing debates about drug checking services and evidence-based drug policy reform, highlighting the persistent tension between criminalization and public health approaches.
Eric L. Sevigny, PhD, Georgia State University, USA
Dr. Eric L. Sevigny, Professor and Interim Chair in the Department of Criminal Justice and Criminology at Georgia State University, conducts policy-relevant research at the intersection of drugs, crime, and society. His research program encompasses three primary areas: drug policy and public health, where he examines the impacts of drug laws and enforcement practices; criminal justice policy evaluation, focusing on interventions like drug courts and sentencing policies; and quantitative methods, where he has developed innovative approaches to measuring drug markets and their consequences. Through research supported by the National Institute on Drug Abuse, the Office of National Drug Control Policy, and other major institutions, Dr. Sevigny has made significant contributions to understanding the effects of marijuana liberalization policies, developing composite indices for measuring drug-related consequences, and advancing methodologies for analyzing drug market dynamics, with his work appearing regularly in leading criminology and policy journals.